Press Releases

The measure forces certain companies to pay for disposal.

The House Subcommittee on Capital Markets held a hearing entitled “The 10th Anniversary of the Sarbanes-Oxley Act.” Jeff Hatfield, President and CEO of Vitae Pharmaceuticals, presented testimony about the effects of regulatory burdens in Sarbanes-Oxley.

Groups issue booklet to help biotechnology and pharmaceutical companies identify pipeline medicines with doping potential.

New bill will update SEC filing status classifications to ease costly regulatory burdens on small public companies 

“This is such an exciting time for the agricultural biotechnology sector because we’re starting to see those next generation products that directly benefit the consumer,” says Dr. Cathleen Enright, Executive Vice President for Food & Agriculture at BIO.

The Biotechnology Industry Organization (BIO) applauds the U.S. Navy’s operational debut of drop-in advanced biofuels in its ships and aircrafts this week at the 22-nation Pacific Rim training exercises off the coast of Hawaii. 

Genetically engineered (GE) varieties of soybeans, cotton and corn are the preferred choice of U.S. farmers over their conventional and organic counterparts, according to newly released data from the U.S. Department of Agriculture (USDA). 

“The BIO Livestock Summit will focus on how we could use animal biotechnology to develop novel health care applications, provide more sustainable food animals and raise livestock that are more environmentally friendly.” 

The process must become more predictable, transparent and efficient.

BIO applauds the Department of Defense’s announced public-private partnership opportunity to support an integrated domestic advanced drop-in biofuel biorefinery and feedstock supply chains to provide the U.S. military with pre-certified blends of biofuels. 

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement on the ruling issued today by the U.S. Supreme Court regarding the Affordable Care Act.

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S. Senate.

The global event for biotechnology brings together industry leaders for networking, partnering, and deal-making.

The 73 to 26 vote against the amendment highlights the value the U.S. Congress places on science-based policymaking and the importance of agricultural innovation.

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on unanimous passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S. House of Representatives.

The Biotechnology Industry Organization (BIO) released a report on the significant economic impact of university and non-profit institution patent licensing on the U.S. economy.

The world’s largest biotechnology event, 2012 BIO International Convention, showcased the global financial and business developments that are shaping the biotechnology sector during the Convention’s second day. 

The Biotechnology Industry Organization(BIO) unveiled a report on the role of intellectual property rights in encouraging upstream research and development as well as downstream commercialization of biotechnology at the 2012 BIO International Convention.

The 4th Annual Scientific American Worldview Report and Scorecard – the most comprehensive country-by-country analysis of biotechnology – reveals the parameters essential for building a successful biotechnology hub in today’s increasingly global industry.

Forty-one state bioscience organizations announce today the formation of the Coalition of State Bioscience Institutes to ensure America’s leadership in bioscience innovation.

The Biotechnology Institute announces today the formation of the nationally coordinated effort of state bioscience organizations. 

The Biotechnology Industry Organization (BIO) announced today that Margaret Foti, Ph.D., M.D. (h.c.), CEO of the American Association  for Cancer Research, has been selected as the Honoree for the 2012 Biotech Humanitarian Award.

BIO hosted two former Secretaries of the U.S. Treasury, Robert E. Rubin and Henry M. Paulson, Jr., during a luncheon keynote session where they discussed the current state and future prospects of the global economy.